NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 251 filers reported holding NOVAVAX INC in Q3 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $268,885 | -89.8% | 32,831 | -75.7% | 0.00% | -100.0% |
Q3 2022 | $2,634,000 | -65.3% | 135,118 | -5.4% | 0.00% | -66.7% |
Q2 2022 | $7,584,000 | +1007.2% | 142,888 | +1557.2% | 0.00% | – |
Q1 2022 | $685,000 | -85.8% | 8,622 | -72.0% | 0.00% | -100.0% |
Q4 2021 | $4,834,000 | -45.4% | 30,830 | -29.2% | 0.00% | -25.0% |
Q3 2021 | $8,857,000 | -27.0% | 43,518 | -25.0% | 0.00% | -33.3% |
Q2 2021 | $12,141,000 | +100.3% | 58,036 | +68.8% | 0.01% | +50.0% |
Q1 2021 | $6,061,000 | -51.2% | 34,387 | -67.8% | 0.00% | -50.0% |
Q4 2020 | $12,431,000 | -24.3% | 106,725 | -30.2% | 0.01% | -42.9% |
Q3 2020 | $16,427,000 | +34.0% | 152,939 | +20.1% | 0.01% | +16.7% |
Q2 2020 | $12,262,000 | +485.9% | 127,327 | -15.6% | 0.01% | +500.0% |
Q1 2020 | $2,093,000 | +94.7% | 150,897 | -44.1% | 0.00% | – |
Q4 2019 | $1,075,000 | +121.6% | 270,052 | +179.3% | 0.00% | – |
Q3 2019 | $485,000 | +4309.1% | 96,698 | +4861.4% | 0.00% | – |
Q2 2019 | $11,000 | – | 1,949 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |